Bruker Corporation (BRKR)
Net profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 113,100 | 427,200 | 296,600 | 277,100 | 157,800 |
Revenue | US$ in thousands | 3,366,400 | 2,964,500 | 2,530,700 | 2,417,900 | 1,987,500 |
Net profit margin | 3.36% | 14.41% | 11.72% | 11.46% | 7.94% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $113,100K ÷ $3,366,400K
= 3.36%
The net profit margin of Bruker Corporation has shown variability over the past five years. Starting at 7.94% on December 31, 2020, the margin increased to 11.46% by December 31, 2021, and continued to rise to 11.72% by December 31, 2022. The trend of growth persisted, reaching a peak of 14.41% on December 31, 2023. However, there was a notable decline in the net profit margin to 3.36% by December 31, 2024. This fluctuation suggests that Bruker Corporation's profitability has been inconsistent, warranting further investigation into the factors driving these changes.
Peer comparison
Dec 31, 2024
Company name
Symbol
Net profit margin
Bruker Corporation
BRKR
3.36%
Avantor Inc
AVTR
10.49%
Bio-Rad Laboratories Inc
BIO
-12.03%
Cytek Biosciences Inc
CTKB
-6.29%
Illumina Inc
ILMN
-27.97%
Mettler-Toledo International Inc
MTD
22.29%
Revvity Inc.
RVTY
9.81%
Waters Corporation
WAT
21.82%